Replies to post #2008 on Enanta Pharmaceuticals Inc (ENTA)

[vinmantoo]

ENTA doses first patient in EDP-721 phase-1:

Good to see and exciting news for ENTA shareholders.

[willyw]

This phase 1 work is being run by
Principal Investigator: ED Gane, MD
https://clinicaltrials.gov/ct2/show/NCT04971512?term=Enanta&cond=hbv&draw=2&rank=3

"Dr. Gane is an investigator for many international clinical trials with particular interest in early phase development of new direct acting antiviral therapies against chronic hepatitis C, hepatitis B, NASH and HCC. He has published almost 350 papers in peer-reviewed journals including The Lancet and The New England Journal of Medicine."

(my comment) Enanta seemed pretty confident about EDP-721. The guy they chose to run the phase 1 trial is also top notch, IMHO.

[semi_infinite]

What is your estimate (or range) of successful HBV combo pricing and total addressable market?